Abstract
“A lucky accident dropped the medicine into our hands”; this is how a publication on August 14, 1886, from Arnold Cahn and Paul Hepp in the Centralblatt für Klinische Medizin began. The history of drug research is punctuated by lucky accidents. As a general rule, detailed knowledge of biological systems was absent. So it is not surprising that the working hypotheses were often wrong, and the obtained results differed from the expectations. The case of accidental success fell into the background over time. Today happenstance as a strategy has been replaced by the arduous and ambitious goal of preparing drugs by using a straightforward approach. The only exception to this is the kind of shotgun-style testing of large and diverse chemical compound libraries, including microbial and plant extracts that is done with the goal of finding new lead structures. In this case, serendipity is desired to find as large and diverse a palette of lead structures (Chaps. 6, “The Classical Search for Lead Structures” and 7, “Screening Technologies for Lead Structure Discovery”) with potential for further optimization (Chaps. 8, “Optimization of Lead Structures” and 9, “Designing Prodrugs”).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Primary Literature
Ban TA (2006) The role of serendipity in drug discovery. Dialogues Clin Neurosci 8:335–344
Burger A (1983) A guide to the chemical basis of drug design. Wiley, New York
de Stevens G (1986) Serendipity and structured research in drug discovery. Fortschr Arzneimittelforsch 30:189–203
Kubinyi H (1999) Chance favors the prepared mind. From serendipity to rational drug design. J Receptor Signal Transd Res 19:15–39
Restak RM (1994) Receptors. Bantam Books, New York
Roberts RM (1989) Serendipity. Accidental discoveries in science. Wiley, New York
Sneader W (1990) Chronology of drug introductions. In: Hansch C, Sammes PG, Taylor JB (eds) Comprehensive medicinal chemistry, vol 1, Kennewell PD (ed). Pergamon Press, Oxford, S.7–S.80
Secondary Literature
Cahn A, Hepp P (1886) Das Antifebrin, ein neues Fiebermittel. Centralblatt für Klinische Medizin 7:561–564
Hofmann A (1993) LSD – mein Sorgenkind, dtv/Klett-Cotta
Sternbach LH (1978) The Benzodiazepine story. Fortschr Arzneimittelforsch 22:229–266
Stütz A (1987) Allylamine derivatives – a new class of active substances in antifungal chemotherapy. Angew Chem Int Ed 26:320–328
von Vámossy Z (1900) Ist Phenolphthalein ein unschädliches Mittel zum Kenntlichmachen von Tresterweinen? Chemiker-Zeitung 24:679–680
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Klebe, G. (2013). In the Beginning, There Was Serendipity. In: Klebe, G. (eds) Drug Design. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-17907-5_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-17907-5_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-17906-8
Online ISBN: 978-3-642-17907-5
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences